SHANGHAI, CHINA -- (MARKET WIRE) -- May 29, 2007 -- Sinobiomed Inc. ("Sinobiomed", or "the Company") (OTCBB: SOBM) is pleased to announce that the Patent Cooperation Treaty (PCT) has accepted the patent application for "a purified recombinant batroxobin with high bioactivity" made by Shanghai Wanxing Bio-pharmaceuticals Co., Ltd. ("Shanghai Wanxing"), the Company's 82% owned subsidiary.
